406
Participants
Start Date
November 30, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
July 31, 2013
COV155
COV155 tablets
placebo
Chesapeake Research Group, LLC, Pasadena
Endeavor Clinical Trails, PA, San Antonio
Jean Brown Research, Inc., Salt Lake City
Lotus Clinical Research, LLC, Pasadena
Anaheim Clinical Trials, Anaheim
Lead Sponsor
Mallinckrodt
INDUSTRY